Search research articles
Contact Us
Filters
Showing results (1-10 of 187) with videos related to
Page
of 19
Sort By:
Pediatric Blood & Cancer
|
January 22, 2010
Moving towards non-invasive assessments of prognosis in osteosarcoma
E Anders Kolb
Current Oncology Reports
|
June 11, 2009
Development of IGF-IR Inhibitors in Pediatric Sarcomas
E Anders Kolb, Richard Gorlick
Blood
|
June 24, 2017
Down syndrome and AML: where do we go from here?
Daisuke Tomizawa, E Anders Kolb
Hematology. American Society of Hematology. Education Program
|
December 6, 2015
Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies
E Anders Kolb, Soheil Meshinchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Challenges in Converting Acute Myeloid Leukemia (AML) Genomics Into AML Clinical Trials
Emi H Caywood, E Anders Kolb
Blood Reviews
|
November 28, 2023
Down syndrome and leukemia: An insight into the disease biology and current treatment options
Sonali P Barwe, E Anders Kolb, Anilkumar Gopalakrishnapillai
Expert Review of Anticancer Therapy
|
February 10, 2012
Progress of oncolytic viruses in sarcomas
Christina K Lettieri, Pooja Hingorani, E Anders Kolb
Advances in Experimental Medicine and Biology
|
June 14, 2014
Oncolytic viruses for potential osteosarcoma therapy
Pooja Hingorani, Valerie Sampson, Christina Lettieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2009
Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo
Pooja Hingorani, Wendong Zhang, Richard Gorlick, et al.
Pediatric Blood & Cancer
|
November 6, 2018
Bone marrow transplant and pediatric multiple myeloma
Kimberly A Davidow, Andrew W Walter, E Anders Kolb
Page
of 19
Search research articles
Search
Showing results (1-10 of 187) with videos related to
Sort By:
Page
of 19
Pediatric Blood & Cancer
|
January 22, 2010
Moving towards non-invasive assessments of prognosis in osteosarcoma
E Anders Kolb
Current Oncology Reports
|
June 11, 2009
Development of IGF-IR Inhibitors in Pediatric Sarcomas
E Anders Kolb, Richard Gorlick
Blood
|
June 24, 2017
Down syndrome and AML: where do we go from here?
Daisuke Tomizawa, E Anders Kolb
Hematology. American Society of Hematology. Education Program
|
December 6, 2015
Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies
E Anders Kolb, Soheil Meshinchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Challenges in Converting Acute Myeloid Leukemia (AML) Genomics Into AML Clinical Trials
Emi H Caywood, E Anders Kolb
Blood Reviews
|
November 28, 2023
Down syndrome and leukemia: An insight into the disease biology and current treatment options
Sonali P Barwe, E Anders Kolb, Anilkumar Gopalakrishnapillai
Expert Review of Anticancer Therapy
|
February 10, 2012
Progress of oncolytic viruses in sarcomas
Christina K Lettieri, Pooja Hingorani, E Anders Kolb
Advances in Experimental Medicine and Biology
|
June 14, 2014
Oncolytic viruses for potential osteosarcoma therapy
Pooja Hingorani, Valerie Sampson, Christina Lettieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2009
Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo
Pooja Hingorani, Wendong Zhang, Richard Gorlick, et al.
Pediatric Blood & Cancer
|
November 6, 2018
Bone marrow transplant and pediatric multiple myeloma
Kimberly A Davidow, Andrew W Walter, E Anders Kolb
Page
of 19